Print

Advaxis, Inc. to Present at the 2012 Biotechnology Industry Organization (BIO) International Convention  
6/18/2012 10:57:20 AM

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that Thomas Moore, Chairman & CEO of Advaxis, will present at the 2012 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), this year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA.
//-->